Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a generally safe and well tolerated antidiabetic drug class with proven efficacy in type 2 diabetes mellitus (T2DM). Recently, a series of large, randomized controlled trials (RCTs) addressing cardiovascular outcomes with DPP-4 inhibitors hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Patoulias, Dimitrios Ioannis, Boulmpou, Aristi, Teperikidis, Eleftherios, Katsimardou, Alexandra, Siskos, Fotios, Doumas, Michael, Papadopoulos, Christodoulos E, Vassilikos, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554356/
https://www.ncbi.nlm.nih.gov/pubmed/34754403
http://dx.doi.org/10.4330/wjc.v13.i10.585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554356/
https://www.ncbi.nlm.nih.gov/pubmed/34754403
http://dx.doi.org/10.4330/wjc.v13.i10.585

Ejemplares similares